267 related articles for article (PubMed ID: 18053161)
1. Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells.
Guo H; Lin Y; Zhang H; Liu J; Zhang N; Li Y; Kong D; Tang Q; Ma D
BMC Mol Biol; 2007 Dec; 8():110. PubMed ID: 18053161
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.
Hubé F; Reverdiau P; Iochmann S; Rollin J; Cherpi-Antar C; Gruel Y
Biol Chem; 2003 Jul; 384(7):1029-34. PubMed ID: 12956419
[TBL] [Abstract][Full Text] [Related]
3. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of TFPI-2 in canine diffuse large B-cell lymphoma.
Ferraresso S; Bresolin S; Aricò A; Comazzi S; Gelain ME; Riondato F; Bargelloni L; Marconato L; Kronnie Gt; Aresu L
PLoS One; 2014; 9(4):e92707. PubMed ID: 24695110
[TBL] [Abstract][Full Text] [Related]
6. Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.
Cui XY; Tinholt M; Stavik B; Dahm AE; Kanse S; Jin Y; Seidl S; Sahlberg KK; Iversen N; Skretting G; Sandset PM
J Thromb Haemost; 2016 Feb; 14(2):387-96. PubMed ID: 26598923
[TBL] [Abstract][Full Text] [Related]
7. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
Manjegowda MC; Gupta PS; Limaye AM
Gene; 2017 May; 614():65-73. PubMed ID: 28286086
[TBL] [Abstract][Full Text] [Related]
8. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.
Lai YH; He RY; Chou JL; Chan MW; Li YF; Tai CK
J Transl Med; 2014 Sep; 12():237. PubMed ID: 25179542
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
[TBL] [Abstract][Full Text] [Related]
11. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
Guo Y; Pakneshan P; Gladu J; Slack A; Szyf M; Rabbani SA
J Biol Chem; 2002 Nov; 277(44):41571-9. PubMed ID: 12198113
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques.
Zawadzki C; Chatelain N; Delestre M; Susen S; Quesnel B; Juthier F; Jeanpierre E; Azzaoui R; Corseaux D; Breyne J; Torpier G; Staels B; Van Belle E; Jude B
Atherosclerosis; 2009 Jun; 204(2):e4-14. PubMed ID: 19081094
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
15. Disordered signaling governing ferroportin transcription favors breast cancer growth.
Chen Y; Zhang S; Wang X; Guo W; Wang L; Zhang D; Yuan L; Zhang Z; Xu Y; Liu S
Cell Signal; 2015 Jan; 27(1):168-76. PubMed ID: 25451081
[TBL] [Abstract][Full Text] [Related]
16. Competitive regulation by transcription factors and DNA methylation in the bovine SIRT5 promoter: Roles of E2F4 and KLF6.
Hong J; Wang X; Mei C; Zan L
Gene; 2019 Feb; 684():39-46. PubMed ID: 30359737
[TBL] [Abstract][Full Text] [Related]
17. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
[TBL] [Abstract][Full Text] [Related]
18. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer.
Rollin J; Iochmann S; Bléchet C; Hubé F; Régina S; Guyétant S; Lemarié E; Reverdiau P; Gruel Y
Br J Cancer; 2005 Feb; 92(4):775-83. PubMed ID: 15685245
[TBL] [Abstract][Full Text] [Related]
19. Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.
Nobeyama Y; Okochi-Takada E; Furuta J; Miyagi Y; Kikuchi K; Yamamoto A; Nakanishi Y; Nakagawa H; Ushijima T
Int J Cancer; 2007 Jul; 121(2):301-7. PubMed ID: 17372906
[TBL] [Abstract][Full Text] [Related]
20. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines.
Jackson P; Millar D; Kingsley E; Yardley G; Ow K; Clark S; Russell PJ
Cancer Lett; 2000 Sep; 157(2):169-76. PubMed ID: 10936677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]